What is it about?
Women with PTEN Hamartoma Tumor Syindrome (PHTS) are offered breast cancer surveillance due to an increased breast cancer lifetime risk. Surveillance guidelines are, however, expert-opinion based due to the lack of data. We aimed to understand the effectiveness of BC surveillance in women with PHTS.
Photo by Victoria Strukovskaya on Unsplash
Why is it important?
In our study, we show that annual breast cancer surveillance with breast Magnetic Resonance Imaging (MRI) starting at age 25 years is effective in detecting early-stage cancers in this under recognised population.
Read the Original
This page is a summary of: The yield and effectiveness of breast cancer surveillance in women with
Hamartoma Tumor Syndrome, Cancer, June 2022, Wiley, DOI: 10.1002/cncr.34326.
You can read the full text:
The following have contributed to this page